Bausch Health Shares Insights on RED-C Phase 3 Clinical Trial Results Bausch Health announces the outcomes of the pivotal Phase 3 RED-C trial assessing a new treatment for hepatic encephalopathy in liver cirrhosis patients.

Bausch Health Shares Insights on RED-C Phase 3 Clinical Trial Results #Canada #Laval #Bausch_Health #RED-C #Hepatic_Encephalopathy